Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBT (2016 - 2025)

Alkermes (ALKS) has disclosed EBT for 16 consecutive years, with $60.4 million as the latest value for Q4 2025.

  • Quarterly EBT fell 64.46% to $60.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $291.4 million through Dec 2025, down 34.32% year-over-year, with the annual reading at $291.4 million for FY2025, 34.32% down from the prior year.
  • EBT for Q4 2025 was $60.4 million at Alkermes, down from $100.7 million in the prior quarter.
  • The five-year high for EBT was $281.8 million in Q2 2023, with the low at -$67.4 million in Q3 2022.
  • Average EBT over 5 years is $60.7 million, with a median of $59.3 million recorded in 2023.
  • The sharpest move saw EBT plummeted 1310.54% in 2021, then surged 947.61% in 2023.
  • Over 5 years, EBT stood at $127.3 million in 2021, then decreased by 10.04% to $114.5 million in 2022, then crashed by 49.06% to $58.3 million in 2023, then skyrocketed by 191.32% to $169.9 million in 2024, then crashed by 64.46% to $60.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at $60.4 million, $100.7 million, and $104.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.